<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Certain Selective Thyroid Hormone Receptor-Beta Agonists, Processes for Manufacturing or Relating to Same, and Products Containing Same; Notice of Commission Final Determination Finding a Violation of Section 337; Issuance of a Limited Exclusion Order and Cease and Desist Orders; Termination of the Investigation</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Certain Selective Thyroid Hormone Receptor-Beta Agonists, Processes for Manufacturing or Relating to Same, and Products Containing Same; Notice of Commission Final Determination Finding a Violation of Section 337; Issuance of a Limited Exclusion Order and Cease and Desist Orders; Termination of the Investigation</h1>
    <p class="timestamp">Published: 2025-06-04 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>Notice is hereby given that the U.S. International Trade Commission has found a violation of section 337 of the Tariff Act of 1930, as amended, in the above-captioned investigation by respondents Ascletis Pharma Inc. of Hangzhou, Zhejiang Province, China; Ascletis Pharmaceuticals Co. Ltd. of Shaoxing, Zhejiang Province, China; Ascletis Bioscience Co., Ltd. of Hangzhou, Zhejiang Province, China; and Gannex Pharma Co., Ltd. of Shanghai, China (collectively, "Corporate Respondents"), based on their...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> International Trade Commission</p>
    <p><strong>Document Number:</strong> 2025-10122</p>
    <p><strong>Publication Date:</strong> 2025-06-04</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2025/06/04/2025-10122/certain-selective-thyroid-hormone-receptor-beta-agonists-processes-for-manufacturing-or-relating-to">https://www.federalregister.gov/documents/2025/06/04/2025-10122/certain-selective-thyroid-hormone-receptor-beta-agonists-processes-for-manufacturing-or-relating-to</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2025-10122</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
